Psychiatry and Neurology, Neurology · Granger, IN
NPI
1811941768
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
14404 State Road 23 Ste B
Granger, IN, 46530
Phone (574) 252-7795
Groups this clinician bills Medicare through
Medicare paid, 2024
$548K
31,159 services
Medicare patients, 2024
423
Average age 68
Drug cost, 2024
$7.2M
9,752 prescriptions
Company payments, 2025
$6,525
From 48 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin R Kristl was code 99214 (office e&m - established), 437 times for 288 patients. In total Kevin R Kristl billed 31,159 services in 59 codes, and Medicare paid $548K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 437 | 288 | $72.74 | $32K |
| 99215 Office E&M - Established | Office | 221 | 159 | $106.68 | $24K |
| 99205 Office E&M - New | Office | 112 | 112 | $135.36 | $15K |
| 99213 Office E&M - Established | Office | 66 | 65 | $54.98 | $3,629 |
| 96413 Chemotherapy Administration | Office | 63 | 18 | $73.97 | $4,660 |
| 95885 Electrical Nerve Conductivity | Office | 54 | 26 | $41.04 | $2,216 |
| 95819 Neurologic | Office | 51 | 51 | $291.25 | $15K |
| 96132 Behavioral Health Services | Office | 28 | 28 | $87.95 | $2,463 |
| 11105 Skin Biopsy | Office | 28 | 14 | $37.04 | $1,037 |
| 96138 Behavioral Health Services | Office | 28 | 28 | $22.41 | $627 |
| 36415 Venipuncture Blood Collection | Office | 18 | 18 | $8.65 | $156 |
| 11104 Skin Biopsy | Office | 14 | 14 | $72.27 | $1,012 |
| 95908 Electrical Nerve Conductivity | Office | 12 | 12 | $75.05 | $901 |
By year: 2022 $112K for 1,065 services; 2023 $338K for 10,904 services; 2024 $548K for 31,159 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 18 | 18 | $8.65 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin R Kristl prescribed most often to Medicare patients was Baclofen, with 553 prescriptions and refills. In total Kevin R Kristl wrote 9,752 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 553 | 905 | 129 | $12K |
| Lacosamide Generic | 430 | 528 | 54 | $53K |
| Levetiracetam Generic | 415 | 826 | 82 | $20K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 395 | 699 | 99 | $5,871 |
| Gabapentin Generic | 347 | 528 | 61 | $4,889 |
| Tizanidine Hcl Generic | 255 | 401 | 54 | $3,596 |
| Memantine Hcl Generic | 238 | 354 | 53 | $4,514 |
| Primidone Generic | 232 | 413 | 51 | $3,914 |
| Donepezil Hcl Generic | 213 | 392 | 54 | $1,937 |
| Ropinirole Hcl Generic | 189 | 382 | 43 | $3,596 |
| Oxcarbazepine Generic | 169 | 269 | 34 | $8,202 |
| Lamotrigine Generic | 165 | 299 | 29 | $4,231 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 148 | 148 | 22 | $5,006 |
| Topiramate Generic | 147 | 193 | 18 | $1,637 |
| Divalproex Sodium Er Divalproex Sodium | 146 | 200 | 26 | $6,478 |
Brand drugs: 1,986 claims; generic drugs: 7,722 claims; opioid claims: 342.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin R Kristl $6,525 ($6,525 in general payments such as food, travel and fees) from 48 companies. The largest payer was Abbvie Inc. with $855.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 52 | $855 |
| Vanda Pharmaceuticals Inc. VNDA | 21 | $525 |
| Pfizer Inc. PFE | 19 | $512 |
| Lundbeck LLC | 14 | $322 |
| Mallinckrodt Hospital Products Inc. | 10 | $315 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $299 |
| Catalyst Pharmaceuticals, Inc. CPRX | 13 | $277 |
| Janssen Biotech, Inc. JNJ | 8 | $275 |
| Argenx US, Inc. ARGX | 11 | $245 |
| Alexion Pharmaceuticals, Inc. AZN | 7 | $192 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.